相关实验视频

Updated: May 1, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

纠正"设计用于抗结核剂的新型INHA抑制剂,使用ab initio碎片分子轨道计算"

Thimpika Pornprom, Bongkochawan Pakamwong, Darunee Sukchit

|March 16, 2026

概括

本研究详细说明了对先前发表的文章DOI的纠正. 更新的信息确保研究人员准确引用和检索科学工作.

科学领域:

科学出版业的科学出版.
图书统计学图书统计学
学术传播学术交流

背景情况:

准确的引用对于科学完整性至关重要.
数字物体识别器 (DOI) 对于定位研究文章至关重要.
在DOI中的错误可能会阻碍研究的可访问性和影响.

研究的目的:

为特定物品的DOI提供纠正通知.
确保研究人员能够准确地访问和引用预期的出版物.

主要方法:

在原始出版物中识别错误的DOI.
检查文章的正确DOI.
发出正式的纠正通知.

主要成果:

错误的DOI已被确定并纠正.
正确的DOI现在可供引用.
确保对科学内容的不间断访问.

结论:

准确的元数据,包括DOI,对于学术记录至关重要.
校正通知是维护研究完整性的重要机制.
这种纠正有助于科学发现的正确归因和检索.

更多相关视频

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...